Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JNC is a diversified Japanese chemical company with businesses spanning liquid crystals, electronic materials, silicones, fibers, fertilizers, aroma chemicals, and selected life science products. Within healthcare and life sciences, the company is best known for Cellufine chromatography media used in biopharmaceutical purification, including antibodies, vaccines, therapeutic proteins, enzymes, and virus-related processes, as well as for polylysine and microbiology testing products. JNC appears to participate in healthcare primarily as a supplier of enabling materials, purification media, and process technologies rather than as a therapeutic drug developer. The company is part of the broader Chisso/JNC group and operates manufacturing, R&D, and commercial facilities in Japan, with international sales through affiliates such as JNC America. For a biotech analyst, JNC is best characterized as an active commercial life science materials and bioprocess company embedded within a larger specialty chemicals organization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JNC.